⨯

  • 16 Jun 20

Feedback's Tom Oakley discusses plans for Bleepa rollout following £5.5mln raise

Feedback's Tom Oakley discusses plans for Bleepa rollout following £5.5mln raise

Feedback plc | FDBK | 158 0 0%
Follow Company Follow Company

    • 113 views

 

Feedback's (LON:FDBK) Tom Oakley speaks to Proactive London's Andrew Scott following the news they've raised £5.05mln through a placing plus they're looking to bring in an additional £540k through an open offer to existing shareholders. He says the cash will be used to develop their flagship product, Bleepa®, as well as engaging and converting NHS trusts to paying customers, developing growth opportunities and 'go to market' strategies with key strategic partners and also exploring opportunities for international expansion.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Feedback raise full-year expectations as sales of Bleepa in NHS and veterinary sectors rise

Companies: Feedback plc

Feedback PLC's Dr Tom Oakley on Bleepa rollout to Pennine Acute Hospitals (PAH) NHS Trust

Companies: Feedback plc

Feedback partner with Amazon Web Services for cloud-based tuberculosis screening services in India

Companies: Feedback plc

Feedback PLC 'very close to standing up some pilots' for its Bleepa app

Companies: Feedback plc

Feedback launch £10m raise to drive 'two enormous opportunities' for CareLocker and Bleepa platform

Companies: Feedback plc

Feedback continue to advance transition into mobile medical communications market with Bleepa

Companies: Feedback plc

Copyright © 2023 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top